Cassava Sciences reported $87.97M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Abbott USD 50.83B 1.76B Jun/2025
Amgen USD 7.43B 1.22B Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
Cassava Sciences USD 87.97M 57.73M Jun/2025
Eisai JPY 828.51B 12.91B Jun/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
Geron USD 259.53M 8.71M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Merck USD 49.06B 725M Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024